drugset / Trial / NCT00264251

Diet, Exercise and/or Rosiglitazone for HIV-Associated Insulin Resistance

NCT00264251

Completed 48 enrolled St. Luke's-Roosevelt Hospital Center
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if, in men and women with excess abdominal fat and insulin resistance, people with HIV infection respond differently than people without HIV to interventions that typically improve body fat distribution and insulin resistance. The specific interventions are: 1. Diet + exercise program. 2. Rosiglitazone treatment. 3. A combination treatment of diet + exercise program and rosiglitazone.

Timeline

Start
2005-07
Primary completion
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosiglitazone Small molecule